4//SEC Filing
Mokari Atabak 4
Accession 0000950170-24-133432
CIK 0001088856other
Filed
Dec 3, 7:00 PM ET
Accepted
Dec 4, 7:34 PM ET
Size
9.4 KB
Accession
0000950170-24-133432
Insider Transaction Report
Form 4
Mokari Atabak
Chief Financial Officer
Transactions
- Tax Payment
Common Stock
2024-12-02$57.68/sh−182$10,498→ 12,336 total - Award
Common Stock
2024-12-02+231→ 12,798 total - Award
Common Stock
2024-12-02$59.21/sh+231$13,678→ 12,567 total
Footnotes (6)
- [F1]These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of restricted stock units.
- [F2]The closing price on November 29, 2024 was used to calculate the withholding obligation.
- [F3]Includes 554 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 1, 2024, 1,448 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 3, 2024 and 400 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 3, 2024. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements.
- [F4]The Reporting Person purchased shares ("Purchase Plan Shares") of the Issuer's common stock pursuant to a purchase plan ("Purchase Plan") established under the Corcept Therapeutics Incorporated 2024 Incentive Award Plan on December 2, 2024.
- [F5]In accordance with the Purchase Plan, the price was established based on the closing price on the day of the purchase.
- [F6]Shares underlie unvested restricted stock awards granted to the Reporting Person by the Issuer under the Purchase Plan. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person remains the beneficial owner of the Purchase Plan Shares through such one-year anniversary.
Documents
Issuer
CORCEPT THERAPEUTICS INC
CIK 0001088856
Entity typeother
Related Parties
1- filerCIK 0001678419
Filing Metadata
- Form type
- 4
- Filed
- Dec 3, 7:00 PM ET
- Accepted
- Dec 4, 7:34 PM ET
- Size
- 9.4 KB